News Releases

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated

Oculis Publishes Notification of Transaction by Person Discharging Managerial Responsibilities

Oculis to Present at the Stifel 2024 Healthcare Conference

Oculis Reports Q3 2024 Financial Results and Provides Company Updates

Oculis Accelerates Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema and Expands its DIAMOND Program Committees

Oculis’ DIAMOND Phase 3 Program in Diabetic Macular Edema to be Presented at Innovate Retina and Eyecelerator 2024

Oculis Announces Appointment of Daniel S. Char as Chief Legal Officer

Oculis and EURETINA Announce the Winner of the Inaugural Ramin Tadayoni Award

Oculis to Present at Upcoming September Investor Conferences